Minnesota Academy of Family Physicians

MARCH 13, 2025

Key Changes: It implements a base year payment rate structure effective January 1, 2026, which will set specific payment rates for various levels of care, including outpatient and residential treatment services, and mandates annual adjustments based on the Medicare Economic Index, beginning January 1, 2027. Read a summary of HF 1005.

Patient-Centered 52

Patient-Centered Telehealth Management Finance 52

Pamela Wible MD

MAY 21, 2025

2026 Physician Vision Quest Retreat Dec 3–7, 2025 ~ 1:1 or small group retreat Craving clarity before the new year? Tax-deductible. CME included. By invitation only. Enjoy a year-end physician wellness retreat—your opportunity to step away from the noise and tune in to divine guidance. Tax-deductible. 30 hours category 2 CME. Can’t travel?

Private Practice 180

Private Practice Consulting Medical Student Engineering 180

FDA Law

MARCH 5, 2024

AstraZeneca also claimed that CMS’s revised guidance on the Negotiation Program for Price Applicability Year 2026 (“Guidance”) interpreted the IRA in two very faulty ways, which violated the Administrative Procedure Act (APA) and harmed and will continue to harm the company. Opinion at 17. see also 42 U.S.C. 1320f-1(e)(1)(A).

Government 64

Government IT Manufacturing Illness 64

FDA Law

NOVEMBER 11, 2024

That means almost certainly no sooner than the second half of 2026. FDA also noted that it has concluded that no safety signal was identified for oral PE at doses permitted under the monograph. Going forward, “The sale of cold medicine containing pseudoephedrine is limited to behind the counter.”

Provider 111

Provider IT Management 111

FDA Law

DECEMBER 23, 2024

This means that, at the current moment, FDA cannot award any priority review vouchers for rare pediatric disease product applications unless it is for a drug that was designated as a drug for a rare pediatric disease not later than December 20, 2024, and such application is approved not later than September 30, 2026.

IT 59

IT Government 59

Plum Health

AUGUST 20, 2023

WSU SOM’s incoming class of 2026 had 300 Students, with 192 in-state and 108 out-of-state students. These medical students will be immersed in the Detroit community over the next 4 years, and upon graduation, many of them will continue to serve the Detroit and Metro Detroit community.

Medical Student 52

Medical Student Community Specialization Medical 52

PEMBlog

OCTOBER 31, 2024

N Engl J Med 2018; 379:2015-2026. There were also no differences in the duration of diarrhea or vomiting, day-care absenteeism, or household transmission of symptoms. Caution While this study provides important insights, it is worth noting that probiotics may still play a role in other health contexts. N Engl J Med. Freedman et al.

Hospital 105

Hospital Illness Patients Provider 105

ABIM

JUNE 20, 2025

ABIM is pleased to announce openings on the Board of Directors , ABIM Council and several Specialty Boards for initial three-year terms beginning July 1, 2026. Applications are due Sunday, July 20, 2025. ABIM Governance provides a meaningful and rewarding opportunity to join outstanding colleagues in service to the profession and to patients.

Government 40

Government Board-Certified Internal Medicine Community 40

ABIM

JUNE 12, 2025

Ruiz, MD, Chair, ABIM Geriatric Medicine Board The Geriatric Medicine Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on March 28, 2025. 4,372 of these (92%) also have a current valid certificate in Internal Medicine. Community Practice in ABIM Governance* Erica N.

Board-Certified 52

Board-Certified Internal Medicine Government Community 52

FDA Law

JUNE 26, 2023

September 1, 2023 will be the selection date for the 10 drugs that will be subject to “maximum fair price” ceilings under Medicare Part D starting in 2026. that Congress may not delegate to an agency the authority to arbitrarily set pricing while “barring judicial review of many decisions critical to pricing determinations under the Act.”

Manufacturing 59

Manufacturing IT Government 59

FDA Law

FEBRUARY 2, 2025

California pharmacists are still able to provide the oral therapeutics without requiring you to visit your primary care physician through January 1, 2026. Please see the Missouri Boards general, non-exhaustive summary addressing these changes at Prescription Delivery Guidance. See rule at 20 CSR 2220-2.013.

Primary Care Physician 59

Primary Care Physician Primary Care Diagnosis Provider 59

FDA Law

OCTOBER 13, 2024

No rare pediatric disease vouchers could be awarded even to designated applications after September 30, 2026. Tobolowsky — The Rare Pediatric Disease Priority Review Voucher program has had a bit of a tumultuous history in its 12 short years of existence. The program, however, has always had a scheduled sunset date.

Government 64

Government IT Education Individual 64

FDA Law

FEBRUARY 11, 2025

However, as we suggested in a recent blog post , the statute did not actually provide any limitations on FDAs authority to grant rare pediatric disease designations , only its authority to grant vouchers. In the meantime, the Pink Sheet confirmed that FDA was continuing to review rare pediatric disease designation requests.

IT 59

IT Families Family Provider 59

FDA Law

SEPTEMBER 22, 2024

Complaints FDA discussed how LDT developers should handle the transition from the current Quality System Regulation (QSR)(21 CFR Part 820) to the recently promulgated Quality Management System Regulation (QMSR) that is scheduled to take effect on February 2, 2026. Gonzalez & Lisa M. It should be noted that 21 CFR 803.18(b)(1)(ii)

Manufacturing 64

Manufacturing Electronics Provider Management 64

FDA Law

OCTOBER 12, 2023

Industry has been asking for Suitability Petition reform for years, either by FDA or mandated by Congress, but, other than a few rejected bills , such requests have basically gone nowhere. Under 21 C.F.R. FDA now has committed under GDUFA III to actually reviewing Suitability Petitions. covering ANDA Suitability Petitions.

Specialization 59

Specialization IT 59

FDA Law

FEBRUARY 21, 2024

One of the major changes is the extension of the transition period from one to two years, with FDA now planning to enforce the QMSR requirements upon the effective date of the final rule on February 2, 2026. The final rule emphasizes risk management activities and risk-based decision making. FDA further retained some definitions in the QSMR.

Manufacturing 59

Manufacturing Management Medical IT 59

FDA Law

OCTOBER 4, 2023

Note that Astellas withdrew its lawsuit after none of its drugs were selected for price reduction in 2026—potentially because that fact cut against its argument for standing. As such, that statute was unjust, confiscatory and violated their constitutional due process rights. The drug was indeed selected on August 29, 2023.

Provider 59

Provider Manufacturing IT Government 59

FDA Law

SEPTEMBER 20, 2021

Notable Dates and Timelines – Program opens, beginning of FY 2023; Expediting reviews fully implemented, by FY 2024; Webpage with detailed criteria for acceptance and participation, October 1, 2022; Interim assessment, end of FY 2025; Public workshop, end of Q2 FY 2026. Notable Dates and Timelines – Applications open, Q4 of FY 2023.

Patient-Centered 52

Patient-Centered Manufacturing Clinic Provider 52

FDA Law

APRIL 14, 2022

The draft MDUFA V commitment letter starts with a 70% goal in FY 2023, but if the de novo decision goal is met in FY 2023 and the fee revenue amount provided for FY 2026 and 2027 is adequate to support performance improvements, FDA plans to increase the goal to 80% in FY 2026. By McKenzie E.

Provider 40

Provider Clinic Medical IT 40

FDA Law

NOVEMBER 16, 2021

In 2025, the Secretary would select no more than 10, 15 in 2026, 15 in 2027, and 20 in 2028 and subsequent years. Select a limited number for negotiation (“selected drugs”) and enter into agreements with their manufacturers to negotiate a “maximum fair price.” That’s a difficult pill to swallow.

Manufacturing 52

Manufacturing Government IT Complication 52

FDA Law

FEBRUARY 13, 2025

Post-market surveillance plans and procedures (PMS) are a requirement under ISO 13485 which will be adopted into FDAs Quality Management System Regulation in 2026. The final guidance clarifies that only an unresolvable failure should preclude implementation; if the failure is resolvable the modification may be implemented after retesting.

Manufacturing 71

Manufacturing Management Specialization Provider 71

FDA Law

DECEMBER 3, 2023

On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. The Discount Program is similar to the CGDP with respect to several requirements and operational processes, and CMS will implement it in a similar manner.

Manufacturing 105

Manufacturing Provider IT Electronics 105

ABIM

JUNE 11, 2025

After similar explorations in gastroenterology , hematology and medical oncology , ABIM announced the development of several new focused LKAs planned for launch in those areas in 2026. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations.

Board-Certified 52

Board-Certified Government Community Education 52

ABIM

JUNE 4, 2025

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025.

Diabetes 52

Diabetes Board-Certified Telehealth Government 52

ABIM

JUNE 24, 2025

Gertz, MD, MACP, Chair, ABIM Hematology Board The Hematology Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on May 2, 2025. A representative from the American Society of Hematology (ASH) joined for a portion of the meeting*.

Board-Certified 40

Board-Certified Board-Certified Physicians Government Community 40

GeriPal

APRIL 3, 2025

I will always, as always, say, you know, you’re welcome to do this in 2026. Annie 02:31 So if you go to the A G S meeting every year, you know that this group of three individuals comprises the AGS literature update. So this is something. This is the plenary to attend. It is a sold out crowd. Of course. We will step aside. Go Cubs, go.

IT 64

IT Hospital Screening Patients 64

Alabama Academy of Family Physicians

FEBRUARY 19, 2025

It then establishes a new Rural Physician Income Tax Credit program, effective January 1, 2026, that provides a $10,000 annual tax credit to qualifying rural physicians for up to four tax years. Sen Arthur Orr, SB 87 proposes significant reforms to enhance midwifery services and birth center regulations.

Insurance 130

Insurance Management Hospital Vaccination 130

ABIM

MAY 30, 2025

The Nephrology Board does not currently have a member who is a private practice general nephrologist and agreed to give special consideration to applicants from non-university, community settings for the next opening that will occur in July 2026. Rodriguez, MD , Chair of the Nephrology Board, and John C.

Board-Certified 40

Board-Certified Government Internal Medicine Private Practice 40

FDA Law

JUNE 14, 2023

In FY 2026 – FY 2027, continue to support products enrolled in previous fiscal years and expand to enroll up to 100 additional products each fiscal year within existing OHTs or expand to additional OHTs, depending on lessons learned from FY 2023 – FY 2025 experience (i.e., up to 125 total products enrolled through FY 2025).

Manufacturing 45

Manufacturing Medical Patient-Centered Appointment 45

FDA Law

JULY 7, 2024

Complaint Handling CLIA regulations, with which all clinical laboratories must already comply, state that a clinical laboratory must “have a system in place to ensure that it documents all complaints and problems reported to the laboratory,” and must “conduct investigations of complaints, when appropriate”. [1]

Manufacturing 64

Manufacturing Provider Physicals Electronics 64

FDA Law

NOVEMBER 17, 2022

Devices in the Safer Technologies Program (STeP) will be included in FY 2026. See Announcement. An independent third party (or parties) will conduct assessments of the TAP Pilot beginning in FY 2024. See Program Website.

Patient-Centered 69

Patient-Centered Provider Medical IT 69

FDA Law

NOVEMBER 22, 2022

CTEs include: Harvesting; Cooling; Initial Packing (other than a food obtained from a fishing vessel); First Land-Based Receiver (for food obtained directly from a fishing vessel); Shipping; Receiving; and. FDA will hold a webinar to provide an in-depth overview of the final rule and Q&A on Dec. 7, 2022 at 1 p.m.

Supply Chain 52

Supply Chain Illness Family Families 52

FDA Law

NOVEMBER 21, 2022

Devices in the Safer Technologies Program (STeP) will be included in FY 2026. See Announcement. An independent third party (or parties) will conduct assessments of the TAP Pilot beginning in FY 2024. See Program Website.

Medical 59

Medical Patient-Centered Provider IT 59

FDA Law

FEBRUARY 4, 2025

With the current lapse in authorization, FDA may only award RPD PRVs for applications that have received an RPD designation before December 20, 2024, andunless reauthorized before thenmay not award any RPD PRVs after September 30, 2026. Below, we discuss some of its downstream impacts on the PRV landscape.

IT 52

IT Vaccination Manufacturing Medical 52

FDA Law

AUGUST 14, 2022

The number will begin in 2026 with 10 drug covered under Medicare Part D and will increase annually to 20 Part B and 20 Part D drugs by 2029 and thereafter, with the selected drugs accumulating from year to year.

Manufacturing 98

Manufacturing Government Vaccination Utilities 98

FDA Law

AUGUST 3, 2021

Section 90006 of the proposed infrastructure bill would further delay implementation of the rebate rule until January 1, 2026, providing the government with an estimated savings of $49 billion. By Faraz Siddiqui — On Monday August 2, 2021, the Senate took up for review H.R. See bipartisan bill summary at 5.

Manufacturing 52

Manufacturing Transportation Government Management 52

FDA Law

JUNE 27, 2022

For example, in the service of highway and other infrastructure enhancements, a moratorium on the rule was imposed until January 1, 2026 under the 2021 Infrastructure and Investment and Jobs Act.

Finance 52

Finance Government Manufacturing Community 52